← Leaderboards
Matthias Arnold
Weill Medical Coll Of Cornell Univ
$2,154,111
Attributed
$4,970,895
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,970,895 · 2
By mechanism
R01$4,970,895 · 2
Top collaborators
- Rima F Kaddurah-Daouk5 shared
- Jan Krumsiek5 shared
- Peter John Meikle5 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Sabine Ehrt$39,683,358
- Angelica Meinhofer$974,170
- Kohta Saito$1,093,093
- Jan Krumsiek$1,660,939
- Yi Su$10,009,654
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMultiple OmicsPharmaceutical PreparationsAffectMetabolomicsMolecularPopulation StudyDrug TargetingMedicineS DiseaseBiological MarkersMachine LearningAgingAmyloid PathologyMetabolic PathwayPathway InteractionsData SetDrug DevelopmentLate Onset Alzheimer DiseaseInvestmentsBiobankLinkAtlasesBrain
Grant awards (10)
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$447,444
R01 · FY2025 · AG
ADMINISTRATIVE SUPPLEMENT - TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease$388,842
R01 · FY2025 · AG
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$74,088
R01 · FY2025 · AG
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$74,088
R01 · FY2025 · AG
TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease$684,233
R01 · FY2024 · AG
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$667,269
R01 · FY2024 · AG
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$725,129
R01 · FY2023 · AG
TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease$717,961
R01 · FY2023 · AG
TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease$566,897
R01 · FY2022 · AG
TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease$624,944
R01 · FY2021 · AG